Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ISRCTN43596477
ISRCTN43596477Completed未知

Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure

niversity Hospital Basel (Switzerland)0 sites820 target enrollmentStarted: September 23, 2005Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
820
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

  1. 2006 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/16644310 2. 2009 results in: http://www.ncbi.nlm.nih.gov/pubmed/19176440 3. 2011 results in: http://www.ncbi.nlm.nih.gov/pubmed/22067089 4. 2012 results in: http://www.ncbi.nlm.nih.gov/pubmed/22424011 5. 2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/24352403 6. 2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/23384944 7. 2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/23666681 8. 2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/24621800 9. 2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/23657728 10. 2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/25576682 11. 2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/25981371 12. 2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/26472682 13. 2016 results in: http://www.ncbi.nlm.nih.gov/pubmed/27503849 14. 2018 post hoc analysis in: http://www.ncbi.nlm.nih.gov/pubmed/29896315

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •1. Heart failure patients aged greater than 60 years
  • •2. New York Heart Association (NYHA) greater than or equal to II
  • •3. CHF hospitalisation within last year
  • •4. NT-BNP level greater than 800 pg/ml (greater than or equal to 75 years), 400 pg/ml (60 - 74 years)

Exclusion Criteria

  • •1. Serum creatinine greater than 220 µmol/l
  • •2. Valve disease needing surgery
  • •3. Disease other than cardiovascular limiting life-expectancy less than 3 years
  • •4. No informed consent

Investigators

Sponsor
niversity Hospital Basel (Switzerland)

Similar Trials

Completed
Not Applicable
et them grow: a new intensive and multimodal treatment for children with borderline intellectual functioning based on movement, cognition and narration of emotions
ISRCTN81710297Fondazione Don Gnocchi - Centro IRCCS S. Maria Nascente60
Completed
Not Applicable
High Intensity Interval Versus Continuous Moderate Intensity Training: Maximizing the Benefits of Exercise in Overweight AdolescentsMetabolismPhysical Fitness
NCT01935323University of Alabama at Birmingham30
Recruiting
Not Applicable
Evidence-Based Neurorehabilitation in Children With CPCerebral Palsy
NCT03128385National Taiwan University Hospital60
Unknown
Phase 3
Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha InterferonAdjuvantStage III Malignant MelanomaInterferon AlphaTherapy
NCT00226408Dermatologic Cooperative Oncology Group600
Completed
Not Applicable
Cost- Effectiveness Study of Brief Interventions for Mood and Anxiety DisordersDepressive DisorderAnxiety Disorder
NCT01643642Leiden University Medical Center182